Exhibit B JOINT FILING AGREEMENT
Exhibit B
Pursuant to Rule 13d-1(k)(1)(iii) of the Securities Exchange Act of 1934, as amended, each of the undersigned agree to the joint filing on behalf of each of them of the Statement on Schedule 13G/A filed herewith (and any amendments thereto), relating to the common stock, par value $0.001 per share, of Cara Therapeutics, Inc.
This Joint Filing Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
| VIFOR (INTERNATIONAL) LTD. | ||
| By: | /s/ Xxxxxxxxxx Xxxxxxx | |
| Name: Xxxxxxxxxx Xxxxxxx | ||
| Title: Head of Finance CSL Vifor | ||
| Date: July 25, 2023 | ||
| By: | /s/ Xxxxxx Xxxxxxx | |
| Name: Xxxxxx Xxxxxxx | ||
| Title: Head FP&A CSL Vifor | ||
| Date: July 25, 2023 |
| VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD. | ||
| By: | /s/ Xxxxxxxxxx Xxxxxxx | |
| Name: Xxxxxxxxxx Xxxxxxx | ||
| Title: Head of Finance CSL Vifor | ||
| Date: July 25, 2023 | ||
| By: | /s/ Xxxxxx Xxxxxxx | |
| Name: Xxxxxx Xxxxxxx | ||
| Title: Head FP&A CSL Vifor | ||
| Date: July 25, 2023 |
| VIFOR PHARMA LTD. | ||
| By: | Vifor Pharma Participations Ltd., as successor by merger to Vifor Pharma Ltd. | |
| By: | /s/ Xxxxxxxxxx Xxxxxxx | |
| Name: Xxxxxxxxxx Xxxxxxx | ||
| Title: Head of Finance CSL Vifor | ||
| Date: July 25, 2023 | ||
| By: | /s/ Xxxxxx Xxxxxxx | |
| Name: Xxxxxx Xxxxxxx | ||
| Title: Head FP&A CSL Vifor | ||
| Date: July 25, 2023 |
| CSL LIMITED | ||
| By: | /s/ Xxxxx Xxxx | |
| Name: Xxxxx Xxxx | ||
| Title: Company Secretary | ||
| Date: July 25, 2023 | ||
